(2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol manufacturers
- Arimoclomol
-
- $54.00
-
2026-04-22
- CAS:289893-25-0
- Purity: 99.81%
- Supply Ability: 10g
- Arimoclomol
-
- $54.00
-
2026-04-22
- CAS:289893-25-0
- Purity: 99.81%
- Supply Ability: 10g
|
| | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol Basic information |
| Product Name: | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol | | Synonyms: | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol;Amrioclomol;(2R-)Arimoclomol NEW;BRX-220 free base;3-Pyridinecarboximidoyl chloride, N-[(2R)-2-hydroxy-3-(1-piperidinyl)propoxy]-, 1-oxide;aggregation,Heat shock proteins,HSP,co-inducer,system,BRX220,motor,Arimoclomol,inhibit,ubiquitin,BRX 220,neurons,misfolded,proteasome,BRX-220,protein,assemblies,clearance,Inhibitor;Arimoclomol, 10 mM in DMSO;(2R-)Arimoclomol | | CAS: | 289893-25-0 | | MF: | C14H20ClN3O3 | | MW: | 313.78 | | EINECS: | | | Product Categories: | | | Mol File: | 289893-25-0.mol | ![(2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol Structure](CAS/GIF/289893-25-0.gif) |
| | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol Chemical Properties |
| Melting point | 93 - 95o C | | Boiling point | 539.2±60.0 °C(Predicted) | | density | 1.32±0.1 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | Aqueous Acid (Slightly), DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 14.03±0.20(Predicted) | | color | White to Off-White | | Stability: | Hygroscopic |
| | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol Usage And Synthesis |
| Uses | Arimoclomol is a co-inducer of HSP that acts through heat shock factor 1 (HSF1) in cells undergoing cellular stress. Has therapeutic potential in motor neuron degenerative diseases. Potential treatment for liposomal storage disorders, such as Niemann-Pick disease type C. | | in vivo | Arimoclomol (BRX-220; 20 mg/kg; orally administered for 5 d) has a protective effect against cholecystokinin-octapeptide (CCK)-induced acute pancreatitis[1]. | Animal Model: | Male Wistar rats weighing 240 to 270 g[1] | | Dosage: | 20 mg/kg | | Administration: | Administered intragastrically, for 5 days | | Result: | Had a protective effect against CCK-induced acute pancreatitis. |
| | IC 50 | HSP |
| | (2R)-1-[[chloro-(1-oxidopyridin-5-yl)methylidene]amino]oxy-3-(1-piperidyl)propan-2-ol Preparation Products And Raw materials |
|